Asunto(s)
Carcinoma de Células Acinares/diagnóstico , Neoplasias Pancreáticas/diagnóstico , Adulto , Biomarcadores de Tumor/análisis , Calcinosis , Carcinoma de Células Acinares/patología , Humanos , Imagen por Resonancia Magnética , Masculino , Neoplasias Pancreáticas/patología , Tomografía Computarizada por Rayos X , UltrasonografíaRESUMEN
Five human nuclear antigens, RNP 70 kD, SS-A, SS-B, Sm-B and Sm-D, were produced in E. coli using the expression vector pSEM. cDNAs encoding these antigens were ligated to a truncated lacZ' gene of the vector and the beta-galactosidase fusion proteins were efficiently expressed as intracellular inclusion bodies after isopropyl-beta-thiogalactopyranoside induction. The antibody reactivities of these fusion proteins were evaluated by Western blot and by ELISA employing panel sera from patients with autoimmune diseases such as systemic lupus erythematosus, Sjögren's syndrome or mixed connective tissue disease. The three fusion proteins, RNP 70 kD, SS-B, and Sm-B, showed good reactivities in both systems, whereas the other two fusion proteins, SS-A and Sm-D, showed poor and no reactivity in both systems, respectively. It can be concluded that RNP 70 kD, SS-B and Sm-B recombinant antigens are useful reagents for the differential diagnosis of the autoimmune diseases.
Asunto(s)
Autoantígenos/inmunología , Sueros Inmunes/inmunología , ARN Citoplasmático Pequeño , Ribonucleoproteínas Nucleares Pequeñas/inmunología , Ribonucleoproteínas/inmunología , Núcleo Celular/inmunología , Escherichia coli/metabolismo , Expresión Génica , Humanos , Proteínas Recombinantes/inmunología , Proteínas Nucleares snRNP , Antígeno SS-BRESUMEN
The cellular nuclear antigen SS-B/La is known to be a major antigenic target to an autoantibody in patients with Sjogren's syndrome and systemic lupus erythematosus. It is useful to detect an anti-SS-B/La antibody from patients' sera in a clinical point of view. We purified SS-B/La from rabbit thymus acetone powder by affinity chromatography with a murine anti-SS-B/La monoclonal antibody (1C3-H7). An enzyme-linked immunosorbent assay method, in which SS-B/La was used to coat a plate, was also successfully established. It is difficult to obtain a large volume of patient's serum with high antibody titer and high specificity as a positive control. We investigated whether or not a positive control from human could be replaced by a murine monoclonal antibody to SS-B/La. The 1C3-H7 was conjugated with a human IgG Fc' fragment using N-gamma-maleimidobutyryloxysuccinimide as a cross-linker. The chemically humanized murine monoclonal antibody (1C3-Fc') was recognized by antiserum specific for human IgG Fc fragment. 1C3-Fc' reacted to SS-B/La but not to other antigens. Furthermore, the titration curve of this conjugate ran parallel with those of patients' sera specific for SS-B/La. It is concluded that a chemically humanized murine monoclonal antibody is useful as a positive control in place of a human patient's serum.
Asunto(s)
Anticuerpos Antinucleares , Anticuerpos Monoclonales , Autoantígenos , Pruebas Inmunológicas/métodos , Ribonucleoproteínas , Animales , Anticuerpos Antinucleares/química , Anticuerpos Monoclonales/química , Especificidad de Anticuerpos , Autoantígenos/aislamiento & purificación , Western Blotting , Humanos , Fragmentos Fc de Inmunoglobulinas , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/inmunología , Ratones , Ribonucleoproteínas/aislamiento & purificación , Síndrome de Sjögren/diagnóstico , Síndrome de Sjögren/inmunología , Especificidad de la Especie , Antígeno SS-BRESUMEN
The in vitro and in vivo antibacterial activities of 6-O-methylerythromycin A (TE-031, A-56268, or clarithromycin) and 6,11-di-O-methylerythromycin A (TE-032) have been compared with those of erythromycin A (EM) and josamycin (JM). TE-031 and TE-032, having the same antibacterial spectra as EM, are active against aerobic Gram-positive bacteria, some Gram-negative bacteria, anaerobic bacteria, L-form bacteria and Mycoplasma pneumoniae. The activity of TE-031 against clinical isolates is equal to or two times more potent than that of EM, whereas TE-032 is slightly less active than EM. The activities of TE-031 and TE-032 are pH dependent (more active at pH 8 than at 5) and are increased by adding serum to medium. TE-031 and TE-032 show dose-related bactericidal activities against Haemophilus influenzae. The therapeutic efficacies of TE-031 and TE-032 against systemic and subcutaneous infections provoked by Gram-positive bacteria in mice are 4- to 35-fold superior to those of EM and JM. TE-031 and TE-032 have demonstrated higher and longer-lasting plasma levels than EM when administered orally to mice, rats or dogs.